Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: A randomized phase III study

Radiotherapy and Oncology

Volumn 43, Issue 1, 1997, Pages 23-28

  Lewin, Freddi ^a   Damber, Lena ^b   Jonsson, Håkan ^b   Andersson, Torsten ^c   Berthelsen, Anne ^d   Biörklund, Anders ^e   Blomqvist, Erik ^f   Evensen, Jan F ^g   Hansen, Hanne S ^h   Hansen, Olfred ⁱ   Jetlund, Olav ^j   Mercke, Claes ^k   Modig, Hans ^b   Overgaard, Marie ^l   Rosengren, Bengt ^m   Tausjö, Johan ^g   Ringborg, Ulrik ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^c Lund's Universitet   (Sweden)

^d GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h Rigshopitalet ^*  (Denmark)

ⁱ ODENSE UNIVERSITY HOSPITAL   (Denmark)

^j TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^k SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^l AARHUS UNIVERSITY HOSPITAL   (Denmark)

^m HAUKELAND UNIVERSITY HOSPITAL   (Norway)

more..

Author keywords

head and neck cancer; multi centre; neoadjuvant chemotherapy; radiotherapy; randomized trial

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0030894240     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(97)01922-1     Document Type: Article

References (18)

1. Decker, D.A., Drelichman, A., Jacobs, J. et al. Adjuvant chemotherapy with cis-diamminodichloroplatinum II and 120 hours infusion 5-fluorouracil in stage II and IV squamous cell carcinoma of the head and neck. Cancer 51: 1353-1355, 1983.
2. Head and Neck Contracts Program. Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the Head and Neck Contracts Program. Cancer 60: 301-311, 1987.
3. Jacobs, C.D., Goffinet, D.R. and Willard, E.F. Head and neck squamous cancers. In: Current Problems in Cancer, p. 71. Editor: C. M. Haskels, Medical Publishers, Chicago, 1990.
4. Jassem, J. and Bartelink, H. Chemotherapy in locally advanced head and neck cancer: a critical reappraisal. Cancer Treat. Rev. 21: 447-462, 1995.
5. Kalbfleisch, J.D. and Prentice, R.L. The Statistical Analysis of Failure Time Data. John Wiley, New York, 1980.
6. Kish, J.A., Weaver, A., Jacobs, J., Cummings, G. and Al Sarraf, M. Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck. Cancer 53: 1819-1824, 1984.
7. Kun, L.E., Toohill, R.J., Holoye, P.Y. et al. A randomized study of adjuvant chemotherapy for cancer of the upper aerodigestive tract. Int. J. Radiat. Oncol. Biol. Phys. 12: 173-178, 1986.
8. Martin, M., Hazan, A., Vergnes, L. et al. Randomized study of 5 fluorouracil and cisplatin as neoadjuvant therapy in head and neck cancer: a preliminary report. Int. J. Radiat. Oncol. Biol. Phys. 19: 973-975. 1990.
9. Merlano, M., Benasso, M., Cavallari, M., Blengio, F. and Rosso, M. Chemotherapy in head and neck cancer. Oral Oncol. Eur. J. Cancer 30B: 283-289, 1994.
10. Munro, A.J. An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer. Br. J. Cancer 71: 83-91, 1995.
11. Paccagnella, A., Orlando, A., Marchiori, C. et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo. J. Natl. Cancer Inst. 86: 265-272, 1994.
12. Rentchler, R.E., Wilbur, D.W., Petti, G.H. et al. Adjuvant methotrexate escalated to toxicity for resectable stage III and IV squamous head and neck carcinomas: a prospective randomized study. J. Clin. Oncol. 5: 278-285, 1987.
13. Schuller, D.E., Metch, B., Mattox, D., Stein, D.W. and McCracken, J.D. Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the southwest oncology group. Laryngoscope 98: 1205-1211, 1988.
14. Stolwijk, C., Wagner, D.J., Van den Broek, P. et al. Randomized neo-adjuvant chemotherapy trial for advanced head and neck cancer. Neth. J. Med. 28: 347-351, 1985.
15. Taylor, S.G., IV, Applebaum, E., Showel, J.L. et al. A randomised trial of adjuvant chemotherapy in head and neck cancer. J. Clin. Oncol. 3: 672-679, 1985.
16. Toohill, R.J., Andersson, T., Byhardt, R.W. et al. Cisplatin and fluorouracil as neoadjuvant therapy in head and neck cancer. Arch. Otolaryngol. Head Neck Surg. 113: 758-761, 1987.
17. Veterans Administration Laryngela Cancer Sstudy Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N. Engl. J. Cancer 324: 1685-1690, 1991.
18. Zubrod, C.G., Schneiderman, M., Frei, E. et al. Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J. Chronic Dis. 11: 7-33, 1960.